20/20 Biolabs Insider Trades
NASDAQ: AIDXHealth CarePrecision InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
20/20 Biolabs insider activity
Over the last 12 months, 20/20 Biolabs insiders reported 5 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Rollins John Woodson (Director) reporting a transaction in 13,029 shares on Feb 19, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AIDX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AIDX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 19, 2026 | COHEN RICHARD MDirector | Conversion | 7,700 | — | Form 4 |
| Feb 19, 2026 | Compton John G.Director | Conversion | 7,669 | — | Form 4 |
| Feb 19, 2026 | Ross Michael A.Director | Conversion | 31 | — | Form 4 |
| Feb 19, 2026 | Rollins John WoodsonDirector | Conversion | 6,135 | — | Form 4 |
| Feb 19, 2026 | Rollins John WoodsonDirector | Conversion | 13,029 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4